71 related articles for article (PubMed ID: 19233143)
1. NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26).
Song M; Park JE; Park SG; Lee DH; Choi HK; Park BC; Ryu SE; Kim JH; Cho S
Biochem Biophys Res Commun; 2009 Apr; 381(4):491-5. PubMed ID: 19233143
[TBL] [Abstract][Full Text] [Related]
2. Dusp26 phosphatase regulates mitochondrial respiration and oxidative stress and protects neuronal cell death.
Eroglu B; Jin X; Deane S; Öztürk B; Ross OA; Moskophidis D; Mivechi NF
Cell Mol Life Sci; 2022 Mar; 79(4):198. PubMed ID: 35313355
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable?
Shillingford SR; Bennett AM
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():617-636. PubMed ID: 36662585
[TBL] [Abstract][Full Text] [Related]
4. An allosteric site on MKP5 reveals a strategy for small-molecule inhibition.
Gannam ZTK; Min K; Shillingford SR; Zhang L; Herrington J; Abriola L; Gareiss PC; Pantouris G; Tzouvelekis A; Kaminski N; Zhang X; Yu J; Jamali H; Ellman JA; Lolis E; Anderson KS; Bennett AM
Sci Signal; 2020 Aug; 13(646):. PubMed ID: 32843541
[TBL] [Abstract][Full Text] [Related]
5. Preparation of Oxidized and Reduced PTP4A1 for Structural and Functional Studies.
Kumar GS
Methods Mol Biol; 2024; 2743():211-222. PubMed ID: 38147218
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets.
Hou X; Sun JP; Ge L; Liang X; Li K; Zhang Y; Fang H
Eur J Med Chem; 2020 Mar; 190():112131. PubMed ID: 32078861
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphatases as emerging targets for cancer immunotherapy.
Qu Z; Dong J; Zhang ZY
Br J Pharmacol; 2023 Dec; ():. PubMed ID: 38116815
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment.
Pardella E; Pranzini E; Leo A; Taddei ML; Paoli P; Raugei G
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 33003469
[TBL] [Abstract][Full Text] [Related]
9. Targeting protein tyrosine phosphatase SHP2 for the treatment of PTPN11-associated malignancies.
Yu B; Liu W; Yu WM; Loh ML; Alter S; Guvench O; Mackerell AD; Tang LD; Qu CK
Mol Cancer Ther; 2013 Sep; 12(9):1738-48. PubMed ID: 23825065
[TBL] [Abstract][Full Text] [Related]
10. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo.
Grosskopf S; Eckert C; Arkona C; Radetzki S; Böhm K; Heinemann U; Wolber G; von Kries JP; Birchmeier W; Rademann J
ChemMedChem; 2015 May; 10(5):815-26. PubMed ID: 25877780
[TBL] [Abstract][Full Text] [Related]
12. A multimeric carcinoembryonic antigen signal inhibits the activation of human T cells by a SHP-independent mechanism: a potential mechanism for tumor-mediated suppression of T-cell immunity.
Lee KA; Bae EA; Song YC; Kim EK; Lee YS; Kim TG; Kang CY
Int J Cancer; 2015 Jun; 136(11):2579-87. PubMed ID: 25379865
[TBL] [Abstract][Full Text] [Related]
13. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.
Chen YN; LaMarche MJ; Chan HM; Fekkes P; Garcia-Fortanet J; Acker MG; Antonakos B; Chen CH; Chen Z; Cooke VG; Dobson JR; Deng Z; Fei F; Firestone B; Fodor M; Fridrich C; Gao H; Grunenfelder D; Hao HX; Jacob J; Ho S; Hsiao K; Kang ZB; Karki R; Kato M; Larrow J; La Bonte LR; Lenoir F; Liu G; Liu S; Majumdar D; Meyer MJ; Palermo M; Perez L; Pu M; Price E; Quinn C; Shakya S; Shultz MD; Slisz J; Venkatesan K; Wang P; Warmuth M; Williams S; Yang G; Yuan J; Zhang JH; Zhu P; Ramsey T; Keen NJ; Sellers WR; Stams T; Fortin PD
Nature; 2016 Jul; 535(7610):148-52. PubMed ID: 27362227
[TBL] [Abstract][Full Text] [Related]
14. Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib.
Sun Y; Meyers BA; Czako B; Leonard P; Mseeh F; Harris AL; Wu Q; Johnson S; Parker CA; Cross JB; Di Francesco ME; Bivona BJ; Bristow CA; Burke JP; Carrillo CC; Carroll CL; Chang Q; Feng N; Gao G; Gera S; Giuliani V; Huang JK; Jiang Y; Kang Z; Kovacs JJ; Liu CY; Lopez AM; Ma X; Mandal PK; McAfoos T; Miller MA; Mullinax RA; Peoples M; Ramamoorthy V; Seth S; Spencer ND; Suzuki E; Williams CC; Yu SS; Zuniga AM; Draetta GF; Marszalek JR; Heffernan TP; Kohl NE; Jones P
Cancer Res; 2020 Nov; 80(21):4840-4853. PubMed ID: 32928921
[TBL] [Abstract][Full Text] [Related]
15. Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer.
LaMarche MJ; Acker M; Argintaru A; Bauer D; Boisclair J; Chan H; Chen CH; Chen YN; Chen Z; Deng Z; Dore M; Dunstan D; Fan J; Fekkes P; Firestone B; Fodor M; Garcia-Fortanet J; Fortin PD; Fridrich C; Giraldes J; Glick M; Grunenfelder D; Hao HX; Hentemann M; Ho S; Jouk A; Kang ZB; Karki R; Kato M; Keen N; Koenig R; LaBonte LR; Larrow J; Liu G; Liu S; Majumdar D; Mathieu S; Meyer MJ; Mohseni M; Ntaganda R; Palermo M; Perez L; Pu M; Ramsey T; Reilly J; Sarver P; Sellers WR; Sendzik M; Shultz MD; Slisz J; Slocum K; Smith T; Spence S; Stams T; Straub C; Tamez V; Toure BB; Towler C; Wang P; Wang H; Williams SL; Yang F; Yu B; Zhang JH; Zhu S
J Med Chem; 2020 Nov; 63(22):13578-13594. PubMed ID: 32910655
[TBL] [Abstract][Full Text] [Related]
16. Role of Non-Receptor-Type Tyrosine Phosphatases in Brain-Related Diseases.
He Y; Nan D; Wang H
Mol Neurobiol; 2023 Nov; 60(11):6530-6541. PubMed ID: 37458988
[TBL] [Abstract][Full Text] [Related]
17. Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus.
Shang P; Simpson JD; Taylor GM; Sutherland DM; Welsh OL; Aravamudhan P; Natividade RDS; Schwab K; Michel JJ; Poholek AC; Wu Y; Rajasundaram D; Koehler M; Alsteens D; Dermody TS
Nat Commun; 2023 May; 14(1):2615. PubMed ID: 37147336
[TBL] [Abstract][Full Text] [Related]
18. Discovery of the SHP2 allosteric inhibitor 2-((3R,4R)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-5-(2,3-dichlorophenyl)-3-methylpyrrolo[2,1-f][1,2,4] triazin-4(3H)-one.
Luo Y; Li J; Zong Y; Sun M; Zheng W; Zhu J; Liu L; Liu B
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):398-404. PubMed ID: 36476046
[TBL] [Abstract][Full Text] [Related]
19. The Discovery of Potent SHP2 Inhibitors with Anti-Proliferative Activity in Breast Cancer Cell Lines.
Ghemrawi R; Khair M; Hasan S; Aldulaymi R; AlNeyadi SS; Atatreh N; Ghattas MA
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457286
[TBL] [Abstract][Full Text] [Related]
20. The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin.
Bohländer F; Weißmüller S; Riehl D; Gutscher M; Schüttrumpf J; Faust S
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
